Preimplantation Genetic Testing Market Size, Share, and Forecast Through 2035
Understanding PGT Categories: PGT-A, PGT-M, and PGT-SR
Preimplantation diagnostics encompass specialized testing categories designed to address distinct reproductive risks. Fertility laboratories select specific screening protocols based on parental genetic carrier status, medical histories, and previous IVF outcomes.
The three primary screening modalities include:
-
PGT-A (Aneuploidy Screening): Evaluates whether an embryo contains the correct baseline number of chromosomes (46). It identifies trisomies (such as Down syndrome) and monosomies, helping clinicians avoid transferring embryos destined for implantation failure or early pregnancy loss.
-
PGT-M (Monogenic/Single-Gene Screening): Designed for couples who are known carriers of specific inherited mutations. It tests embryos for monogenic disorders like spinal muscular atrophy, Tay-Sachs, or thalassemia, ensuring non-affected embryos are prioritized for transfer.
-
PGT-SR (Structural Rearrangements): Targets embryos from parents carrying balanced translocations, inversions, or structural chromosomal anomalies. It detects unbalanced duplications or deletions that could lead to severe developmental defects.
Biopsy timing plays a crucial role in diagnostic accuracy. Historically, biopsies were performed on Day 3 blastomeres (cleavage stage). Today, industry standards have overwhelmingly migrated to Day 5 or Day 6 trophectoderm biopsies at the blastocyst stage. Extracting 5–10 cells from the outer placental layer spares the inner cell mass (which forms the fetus) and yields more starting DNA, drastically improving sequencing reliability.
Emerging non-invasive techniques (niPGT) represent the next frontier. By analyzing cell-free DNA secreted into the embryo culture medium, researchers aim to perform genetic screening without physical cellular biopsy, eliminating mechanical stress on the embryo. Detailed breakdowns of technology adoption rates and panel modalities are detailed in the Preimplantation Genetic Testing Market study. These combined advances continue to elevate the precision and safety of reproductive genomics.
Gain valuable insights through comprehensive industry analysis:
